1. Home
  2. CADL vs AVBC Comparison

CADL vs AVBC Comparison

Compare CADL & AVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$4.99

Market Cap

455.8M

Sector

Health Care

ML Signal

N/A

Logo Avidia Bancorp Inc.

AVBC

Avidia Bancorp Inc.

N/A

Current Price

$21.18

Market Cap

418.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
AVBC
Founded
1999
1869
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
455.8M
418.6M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
CADL
AVBC
Price
$4.99
$21.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
2
Target Price
$17.67
★ $27.25
AVG Volume (30 Days)
★ 1.4M
93.2K
Earning Date
11-12-2026
10-22-2026
Dividend Yield
N/A
★ 1.12%
EPS Growth
★ 58.62
N/A
EPS
N/A
★ 1.18
Revenue
★ $125,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.43
P/E Ratio
★ N/A
$18.16
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$15.28
52 Week High
$14.00
$24.00

Technical Indicators

Market Signals
Indicator
CADL
AVBC
Relative Strength Index (RSI) 25.65 29.36
Support Level $4.62 $19.67
Resistance Level $5.51 $21.44
Average True Range (ATR) 0.70 0.58
MACD -0.33 -0.21
Stochastic Oscillator 1.62 5.73

Price Performance

Historical Comparison
CADL
AVBC

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About AVBC Avidia Bancorp Inc.

Avidia Bancorp Inc business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial and industrial loans, one-to four-family residential mortgage loans, and commercial real estate loans.

Share on Social Networks: